Severity of post-ERCP pancreatitis directly proportional to the invasiveness of endoscopic intervention: A pilot study in a canine model

Endoscopy

Volumn 40, Issue 6, 2008, Pages 506-512

  Buscaglia, J M ^a   Simons, B W ^a   Prosser, B J ^a   Ruben, D S ^a   Giday, S A ^a   Magno, P ^a   Clarke, J O ^a   Shin, E J ^a   Kalloo, A N ^a   Kantsevoy, S V ^a   Gabrielson, K L ^a   Jagannath, S B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACINAR CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CELL DEATH; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DOG; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HYPERAMYLASEMIA; MALE; NONHUMAN; PANCREAS DUCT STENOSIS; PANCREATITIS; PATHOLOGIST; PILOT STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; SPHINCTEROTOMY; STENT;

ACUTE DISEASE; ANIMALS; BIOPSY, NEEDLE; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DISEASE MODELS, ANIMAL; DOGS; IMMUNOHISTOCHEMISTRY; MALE; PANCREATIC FUNCTION TESTS; PANCREATITIS; PROBABILITY; RANDOM ALLOCATION; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 46249129934     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995653     Document Type: Article

References (50)

1. Marks JM, Dunkin BJ, Shillingstad BL et al. Pretreatment with allopurinol diminishes pancreatography-induced pancreatitis in a canine model. Gastrointest Endosc 1998; 48: 180-183
2. Freeman ML, Nelson DB, Sherman S et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335: 909-918
3. Bilbao MK, Dotter CT, Lee TG et al. Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases. Gastroenterology 1976; 70: 314-320
4. Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 2004; 59: 845-864
5. Pfau PR, Mosley RG, Said A et al. Comparison of the effect of non-ionic and ionic contrast agents on pancreatic histology in a canine model. JOP 2006; 7: 27-33
6. Cotton PB, Lehman G, Vennes J et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1999; 37: 383-393
7. Cheng CL, Sherman S, Watkins JL et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 2006; 101: 139-147
8. Testoni PA. Facts and fiction in the pharmacologic prevention of post-ERCP pancreatitis: a never-ending story. Gastrointest Endosc 2006; 64: 732-734
9. Cavallini G, Tittobello A, Frulloni L et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy - Italian Group. N Engl J Med 1996; 335: 919-923
10. Katsinelos P, Kountouras J, Chatzis J et al. High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial. Gastrointest Endosc 2005; 61: 407-415
11. Murray B, Carter R, Imrie C et al. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003; 124: 1786-1791
12. Deviere J, Le Moine O, Van Laethem JL et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001; 120: 498-505
13. Sudhindran S, Bromwich E, Edwards PR. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 2001; 88: 1178-1782
14. Raty S, Sand J, Pulkkinen M et al. Post-ERCP pancreatitis: reduction by routine antibiotics. J Gastrointest Surg 2001; 5: 339-345
15. Moreto M, Zaballa M, Casado I et al. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial. Gastrointest Endosc 2003; 57: 1-7
16. Binmoeller KF, Harris AG, Dumas R et al. Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Gut 1992; 33: 1129-1133
17. Prat F, Amaris J, Ducat B et al. Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study. Gastrointest Endosc 2002; 56: 202-208
18. Sand J, Nordback I. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography. Digestion 1993; 54: 105-111
19. Schwartz JJ, Lew RJ, Ahmad NA et al. The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis. Gastrointest Endosc 2004; 59: 179-184
20. Cunliffe WJ, Cobden I, Lavelle MI et al. A randomised, prospective study comparing two contrast media in ERCP. Endoscopy 1987; 19: 201-202
21. Hannigan BF, Keeling PW, Slavin B et al. Hyperamylasemia after ERCP with ionic and non-ionic contrast media. Gastrointest Endosc 1985; 31: 109-110
22. Johnson GK, Geenen JE, Bedford RA et al. A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group. Gastrointest Endosc 1995; 42: 312-316
23. O'Connor HJ, Ellis WR, Manning AP et al. Iopamidol as contrast medium in endoscopic retrograde pancreatography: a prospective randomised comparison with diatrizoate. Endoscopy 1988; 20: 244-247
24. Sherman S, Hawes RH, Rathgaber SW et al. Post-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent. Gastrointest Endosc 1994; 40: 422-427
25. Weiner GR, Geenen JE, Hogan WJ et al. Use of corticosteroids in the prevention of post-ERCP pancreatitis. Gastrointest Endosc 1995; 42: 579-583
26. Budzynska A, Marek T, Nowak A et al. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Endoscopy 2001; 33: 766-772
27. De Palma GD, Catanzano C. Use of corticosteroids in the prevention of post-ERCP pancreatitis: results of a controlled prospective study. Am J Gastroenterol 1999; 94: 982-985
28. Dumot JA, Conwell DL, O'Connor JB et al. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial. Am J Gastroenterol 1998; 93: 61-65
29. Sherman S, Blaut U, Watkins JL et al. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study. Gastrointest Endosc 2003; 58: 23-29
30. Manolakopoulos S, Avgerinos A, Vlachogiannakos J et al. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial. Gastrointest Endosc 2002; 55: 470-475
31. Rongione AJ, Kusske AM, Kwan K et al. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology 1997; 112: 960-967
32. Van Laethem JL, Marchant A, Delvaux A et al. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995; 108: 1917-1922
33. Dumot JA, Conwell DL, Zuccaro G et al. A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis. Am J Gastroenterol 2001; 96: 2098-2102
34. Rabenstein T, Roggenbuck S, Framke B et al. Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP? Gastrointest Endosc 2002; 55: 476-483
35. Masci E, Cavallini G, Mariani A et al. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis. Am J Gastroenterol 2003; 98: 2182-2186
36. Andriulli A, Leandro G, Niro G et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 2000; 51: 1-7
37. Arvanitidis D, Anagnostopoulos GK, Giannopoulos D et al. Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial. J Gastroenterol Hepatol 2004; 19: 278-282
38. Bordas JM, Toledo-Pimentel V, Llach J et al. Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study. Gastrointest Endosc 1998; 47: 230-234
39. Poon RT, Yeung C, Lo CM et al. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc 1999; 49: 593-598
40. Sternlieb JM, Aronchick CA, Retig JN et al. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. Am J Gastroenterol 1992; 87: 1561-1566
41. Testoni PA, Bagnolo F, Andriulli A et al. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial. Aliment Pharmacol Ther 2001; 15: 965-972
42. Qin HL, Su ZD, Gao Q et al. Early intrajejunal nutrition: bacterial translocation and gut barrier function of severe acute pancreatitis in dogs. Hepatobiliary Pancreat Dis Int 2002; 1: 150-154
43. Chen J, Wang XP, Liu P et al. Effects of continuous early enteral nutrition on the gut barrier function in dogs with acute necrotizing pancreatitis. Zhonghua Yi Xue Za Zhi 2004; 84: 1726-1731
44. Zhu Q, Yuan Y, Xia L et al. The effect of sandostatin on sphincter of Oddi in acute severe pancreatitis in dogs. Zhonghua Nei Ke Za Zhi 1999; 38: 747-749
45. Boerma D, Straatsburg IH, Offerhaus GJ et al. Experimental model of obstructive chronic pancreatitis in pigs. Dig Surg 2003; 20: 520-526
46. Evans HE. The digestive apparatus and abdomen. In: Miller's anatomy of the dog. 2nd edn. Philadelphia: Saunders, 1983: 456-460
47. Newman SJ, Steiner JM, Woosley K et al. Histologic assessment and grading of the exocrine pancreas in the dog. J Vet Diagn Invest 2006; 18: 115-118
48. Tarnasky PR, Palesch YY, Cunningham JT et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998; 115: 1518-1524
49. Tarnasky PR. Mechanical prevention of post-ERCP pancreatitis by pancreatic stents: results, techniques, and indications. JOP 2003; 4: 58-67
50. Pezzilli R, Venturi M, Morselli-Labate AM et al. Serum trypsinogen activation peptide in the assessment of the diagnosis and severity of acute pancreatic damage: a pilot study using a new determination technique. Pancreas 2004; 29: 298-305